# Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

> **NCT00004246** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Fludarabine Phosphate
- **RADIATION:** Radiation Therapy (RT)

## Key facts

- **NCT ID:** NCT00004246
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06-07
- **Primary completion:** 2002-12-02
- **Final completion:** 2002-12-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004246, "Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00004246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*